![](/Html/Index/images/a.gif)
![](/Html/Index/images/dh-wei.gif)
- API
- Ivabradine hydrochlorid
- Rivaroxaban
- Apixaban
- Dabigatran etexilate
- Safinamide
- Ticlopidine hydrochloride
- Mirtazapine
- Clopidogrel bisulfate
- Duloxetine hydrochloride
- Rebamipide
- Intermediates
- Duloxetine intermediate
- Clopidogrel intermediate
- Mirtazapine intermediates
- Dabigatran etexilate intermediates
- Lurasidone intermediates
- Bepotastine intermediates
- Asenapine Intermediates
- Drotaverine intermediates
- Prasugrel Intermediates
- Ivabradine、Verapamil, Denopamine intermediates
- Moxifloxacin intermediate
- Ticagrelor intermediate <Under Development>
- Canagliflozin intermediate
- Ivabradine intermediate
![](/Html/Index/images/tel.jpg)
Address: Zhejiang Provincial Chemical and Medical Raw Material Base Linhai Zone, Duqiao Town, Linhai City, Zhejiang Province, 317016, China
Tel / Fax: 0576-85588211
Tel / Fax: 0576-85588211
![](/Html/Index/images/a.gif)
![](/Html/Index/images/dh-wei.gif)
Category | Canagliflozin intermediate |
Product Name | 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene |
Structure | ![]() |
CAS No. | 1030825-20-7 |
Specification |
In-house |